Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 293

Similar articles for PubMed (Select 19342639)

1.

Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development.

Mycko MP, Ferrero I, Wilson A, Jiang W, Bianchi T, Trumpp A, MacDonald HR.

J Immunol. 2009 Apr 15;182(8):4641-8. doi: 10.4049/jimmunol.0803394.

2.
3.

Intrathymic proliferation wave essential for Valpha14+ natural killer T cell development depends on c-Myc.

Dose M, Sleckman BP, Han J, Bredemeyer AL, Bendelac A, Gounari F.

Proc Natl Acad Sci U S A. 2009 May 26;106(21):8641-6. doi: 10.1073/pnas.0812255106. Epub 2009 May 7.

4.

c-Myc controls the development of CD8alphaalpha TCRalphabeta intestinal intraepithelial lymphocytes from thymic precursors by regulating IL-15-dependent survival.

Jiang W, Ferrero I, Laurenti E, Trumpp A, MacDonald HR.

Blood. 2010 Jun 3;115(22):4431-8. doi: 10.1182/blood-2009-11-254698. Epub 2010 Mar 22.

6.

Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.

Wingender G, Berg M, Jüngerkes F, Diehl L, Sullivan BA, Kronenberg M, Limmer A, Knolle PA.

Eur J Immunol. 2006 Mar;36(3):570-82.

PMID:
16506291
7.

Identification of CD4(-)CD8(-) double-negative natural killer T cell precursors in the thymus.

Dashtsoodol N, Watarai H, Sakata S, Taniguchi M.

PLoS One. 2008;3(11):e3688. doi: 10.1371/journal.pone.0003688. Epub 2008 Nov 10.

8.

Development and selection of Valpha l4i NKT cells.

MacDonald HR, Mycko MP.

Curr Top Microbiol Immunol. 2007;314:195-212. Review.

PMID:
17593662
9.

Characterization of the early stages of thymic NKT cell development.

Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A.

J Exp Med. 2005 Aug 15;202(4):485-92. Epub 2005 Aug 8.

11.

Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets.

Johnston B, Kim CH, Soler D, Emoto M, Butcher EC.

J Immunol. 2003 Sep 15;171(6):2960-9.

12.

A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.

Pellicci DG, Hammond KJ, Uldrich AP, Baxter AG, Smyth MJ, Godfrey DI.

J Exp Med. 2002 Apr 1;195(7):835-44.

14.
15.

Does the developmental status of Valpha14i NKT cells play a role in disease?

Matsuda JL, Gapin L.

Int Rev Immunol. 2007 Jan-Apr;26(1-2):5-29. Review.

PMID:
17454262
16.

Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity.

Campos RA, Szczepanik M, Itakura A, Akahira-Azuma M, Sidobre S, Kronenberg M, Askenase PW.

J Exp Med. 2003 Dec 15;198(12):1785-96.

17.

NKT cell responses to glycolipid activation.

Tefit JN, Davies G, Serra V.

Methods Mol Biol. 2010;626:149-67. doi: 10.1007/978-1-60761-585-9_11.

PMID:
20099127
18.

c-Myc acts downstream of IL-15 in the regulation of memory CD8 T-cell homeostasis.

Bianchi T, Gasser S, Trumpp A, MacDonald HR.

Blood. 2006 May 15;107(10):3992-9. Epub 2006 Jan 31.

19.

Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.

Voyle RB, Beermann F, Lees RK, Schümann J, Zimmer J, Held W, MacDonald HR.

J Exp Med. 2003 Apr 7;197(7):919-25.

20.

Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.

Wahl C, Bochtler P, Schirmbeck R, Reimann J.

J Immunol. 2007 Feb 15;178(4):2083-93.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk